MoonLake Immunotherapeutics (MLTX)
52.07
+2.25
(+4.52%)
USD |
NASDAQ |
Nov 21, 14:46
MoonLake Immunotherapeutics Market Cap: 3.284B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 3.142B |
| November 19, 2024 | 3.111B |
| November 18, 2024 | 3.061B |
| November 15, 2024 | 3.079B |
| November 14, 2024 | 3.311B |
| November 13, 2024 | 3.220B |
| November 12, 2024 | 3.272B |
| November 11, 2024 | 3.399B |
| November 08, 2024 | 3.265B |
| November 07, 2024 | 3.195B |
| November 06, 2024 | 3.247B |
| November 05, 2024 | 3.004B |
| November 04, 2024 | 2.926B |
| November 01, 2024 | 2.949B |
| October 31, 2024 | 2.927B |
| October 30, 2024 | 2.963B |
| October 29, 2024 | 3.038B |
| October 28, 2024 | 3.029B |
| October 25, 2024 | 2.944B |
| October 24, 2024 | 2.913B |
| October 23, 2024 | 2.937B |
| October 22, 2024 | 3.026B |
| October 21, 2024 | 3.091B |
| October 18, 2024 | 3.085B |
| October 17, 2024 | 3.031B |
| Date | Value |
|---|---|
| October 16, 2024 | 3.097B |
| October 15, 2024 | 3.026B |
| October 14, 2024 | 3.083B |
| October 11, 2024 | 3.085B |
| October 10, 2024 | 2.963B |
| October 09, 2024 | 3.007B |
| October 08, 2024 | 3.143B |
| October 07, 2024 | 3.262B |
| October 04, 2024 | 3.485B |
| October 03, 2024 | 3.278B |
| October 02, 2024 | 3.267B |
| October 01, 2024 | 3.261B |
| September 30, 2024 | 3.179B |
| September 27, 2024 | 3.107B |
| September 26, 2024 | 3.231B |
| September 25, 2024 | 3.195B |
| September 24, 2024 | 3.412B |
| September 23, 2024 | 3.484B |
| September 20, 2024 | 3.398B |
| September 19, 2024 | 3.378B |
| September 18, 2024 | 3.340B |
| September 17, 2024 | 3.207B |
| September 16, 2024 | 3.143B |
| September 13, 2024 | 3.216B |
| September 12, 2024 | 3.210B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
173.18M
Minimum
May 16 2022
3.861B
Maximum
Feb 12 2024
1.835B
Average
2.531B
Median
Market Cap Benchmarks
| Novartis AG | 207.20B |
| AC Immune SA | 320.58M |
| CRISPR Therapeutics AG | 3.958B |
| Addex Therapeutics Ltd | 8.154M |
| NLS Pharmaceutics Ltd | 12.63M |
Market Cap Related Metrics
| Price to Book Value | 6.726 |
| Price | 52.07 |
| Earnings Yield | -2.44% |